High‐dose CD20‐targeted radioimmunotherapy‐based autologous transplantation improves outcomes for persistent mantle cell lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|171|5|788-797

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.171, Iss.5, 2015-12, pp. : 788-797

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Lymphoma Experience and Its Potential Relevance to Solid Tumors

By  

Oncology, Vol. 58, Iss. 3, 2000-04 ,pp. : 198-206

Karger

Access to resources Recommend Favorite

High‐dose therapy and autologous stem cell transplantation for children with HIV‐associated non‐Hodgkin lymphoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 49, Iss. 7, 2007-12 ,pp. : 984-987

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Dose Therapy and Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Disease: Outcome Based on a Prognostic Model

By  

Acta Haematologica, Vol. 110, Iss. 4, 2003-12 ,pp. : 173-178

Karger

Access to resources Recommend Favorite

Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies

By Dillman R.  

Clinical and Experimental Medicine, Vol. 6, Iss. 1, 2006-03 ,pp. : 1-12

Springer Publishing Company

Access to resources Recommend Favorite

Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?

By Cheng Yee Chung   Ueno Naoto T  

Women's Health, Vol. 6, Iss. 4, 2010-07 ,pp. : 481-485

Future Medicine

Access to resources Recommend Favorite